Pharmaceuticals & Life Sciences · Clinical Data Management & Biostatistics

Biostatistics & Statistical Programming

Automates→Stable

Available Now

Production-ready. Commercial solutions exist and organizations are actively deploying.

Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.

What You Do Today

Design statistical analysis plans, perform primary and sensitivity analyses for clinical trials, and produce Tables, Listings, and Figures (TLFs) for regulatory submissions. Program analysis datasets in SAS or R per CDISC ADaM standards.

AI Technologies

Automated TLF GenerationStatistical Programming AIBayesian Analysis PlatformsAnalysis Plan Validation

Roles Involved

Who works on this

Digital Strategy LeaderDigital Transformation LeaderChief Data OfficerChief of StaffInnovation LeadAI/ML Strategy LeadAI Governance LeadBiostatisticianData EngineerData AnalystTechnical WriterEnterprise Architect

VP/SVPDirectorIndividual ContributorCross-Functional

How It Works

AI automates TLF generation from ADaM datasets using standardized templates. Statistical programming assistants generate validated SAS/R code from analysis plan specifications. Bayesian analysis platforms enable adaptive trial designs with real-time posterior probability calculations.

What Changes

Standard TLF production becomes largely automated. Biostatisticians focus on complex analyses, interpretation, and regulatory strategy rather than routine programming.

What Stays the Same

Designing analysis plans that address the clinical question rigorously, interpreting results in the context of the disease and treatment landscape, and defending statistical approaches to regulatory reviewers require deep statistical and clinical expertise.

Cross-Industry Concepts

statistical analysis programming automation regulatory reporting

Evidence & Sources

•ICH E9 statistical principles for clinical trials
•FDA statistical review guidance

Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.

Last reviewed: March 2026

What To Do Next

This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.

Establish Your Baseline

Know where you are before you move

Before adopting AI tools for biostatistics & statistical programming, document your current state in clinical data management & biostatistics.

•

Map your current process: Document how biostatistics & statistical programming works today — who does what, how long each step takes, and where the bottlenecks are. Use your data warehouse data to establish a factual baseline.

•

Identify the judgment calls: Designing analysis plans that address the clinical question rigorously, interpreting results in the context of the disease and treatment landscape, and defending statistical approaches to regulatory reviewers require deep statistical and clinical expertise. — these are the boundaries AI won't cross. Know them before you start.

•

Check your data readiness: AI tools for clinical data management & biostatistics need clean, accessible data. Check whether your data warehouse has the historical data, integrations, and quality to support Automated TLF Generation tools.

Without a baseline, you can't tell whether AI actually improved biostatistics & statistical programming or just changed who does it.

Define Your Measures

What to track and how to calculate it

report delivery time

How to calculate

Measure report delivery time for biostatistics & statistical programming before and after AI adoption. Pull from your data warehouse.

Why it matters

This is the most direct indicator of whether AI is adding value to clinical data management & biostatistics.

self-service adoption rate

How to calculate

Track self-service adoption rate using the same methodology you use today. Don't change how you measure just because you changed how you work.

Why it matters

Speed without quality is just faster mistakes. Measure both together.

When to check: Check after 30 days of consistent use, then quarterly.

The commitment: Give new tools at least 30 days before judging. The first week is always awkward.

What NOT to measure: Don't measure AI adoption rate as a goal. Measure outcomes. If the tool helps with biostatistics & statistical programming, people will use it.